XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 103 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $17,228,002 | +2.5% | 7,656,890 | +0.7% | 0.00% | – |
| Q1 2024 | $16,809,795 | +0.9% | 7,606,242 | +7.3% | 0.00% | – |
| Q4 2023 | $16,652,910 | +27.4% | 7,086,345 | +0.9% | 0.00% | – |
| Q3 2023 | $13,068,664 | -28.2% | 7,026,164 | +1.1% | 0.00% | – |
| Q2 2023 | $18,213,189 | +63.3% | 6,951,599 | +1.6% | 0.00% | – |
| Q1 2023 | $11,150,967 | +27.1% | 6,841,084 | +3.7% | 0.00% | – |
| Q4 2022 | $8,775,281 | -13.6% | 6,597,956 | +1.4% | 0.00% | – |
| Q3 2022 | $10,156,000 | +4.8% | 6,509,733 | +3.4% | 0.00% | – |
| Q2 2022 | $9,692,000 | -27.3% | 6,293,481 | +20.8% | 0.00% | – |
| Q1 2022 | $13,333,000 | -11.0% | 5,208,186 | +1.8% | 0.00% | – |
| Q4 2021 | $14,989,000 | – | 5,115,623 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,113,348 | $11,505,033 | 58.31% |
| Rosalind Advisors, Inc. | 3,120,170 | $7,020,382 | 5.40% |
| MPM BioImpact LLC | 4,830,526 | $10,868,684 | 1.69% |
| Knott David M Jr | 820,000 | $1,845 | 0.74% |
| CenterBook Partners LP | 1,465,875 | $3,298,219 | 0.20% |
| Redmile Group, LLC | 1,046,587 | $2,354,821 | 0.14% |
| Alpine Global Management, LLC | 300,000 | $675,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 605,663 | $1,363 | 0.10% |
| Invenomic Capital Management LP | 592,078 | $1,332,176 | 0.06% |
| Powell Investment Advisors, LLC | 50,000 | $112,500 | 0.06% |